Clinical trial · Observational
Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases Via Radiomics
Distinguishing Retroperitoneal Fibrosis and Sarcoma from Other Retroperitoneal Diseases on CT Scans Via an Extended-Radiomics Approach: a Multi-Centric, International Retrospective Analysis.
NCT06741423CI-TRIAL-00083922active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A retrospective study utilizing archived CT scans of patients diagnosed with retroperitoneal fibrosis, sarcoma or other malignancies (i.e. lymphoma, germ cell tumors, metastasis, infections, ganglioneuromas) in order to implement a radiomics algorithm which is able to differentiate between these malignancies.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Retroperitoneal Fibrosis | — | UNRESOLVED | — |
| Retroperitoneal Sarcoma | Retroperitoneal Sarcoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiomics Algortihm | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- retroperitoneal fibrosis
- description
- All recruited patients with retroperitoneal fibrosis
- interventionNames
- Other: Radiomics Algortihm
- label
- retroperitoneal sarcoma
- description
- All recruited patients with retroperitoneal sarcoma
- interventionNames
- Other: Radiomics Algortihm
- label
- other retroperitoneal diseases
- description
- All recruited patients with other retroperitoneal malignancies
- interventionNames
- Other: Radiomics Algortihm
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Patients of any age or gender. * CT scans confirming the presence of a retroperitoneal mass. * Confirmed diagnosis of retroperitoneal fibrosis, sarcoma or other malignancies (i.e. lymphoma, germ cell tumors, metastasis, infections, ganglioneuromas) through pathology reports or clinical follow-up. Exclusion Criteria: * Poor quality CT scans where the region of interest is not clearly visible. * Previous treatments or surgeries that might alter the radiomic features of the tumors.
References
Publications (0)
Data not yet available
No reference posted for this study.